Non-tuberculous mycobacterial infection in children with cancer

  • J. C. Graham
  • D. A. Tweddle
  • D. R. Jenkins
  • C. Pollitt
  • S. J. Pedler
Note

Abstract

Reported here is the clinical presentation and management of patients with rapidly growing non-tuberculous mycobacterial infection diagnosed in a paediatric oncology unit. A retrospective analysis that correlated patient isolates with the children's cancer registry revealed two cases of non-tuberculous mycobacterial infection; both had been observed within the last 6 years and were due toMycobacterium chelonae. The first case was line-associated and the second was a disseminated infection. In both cases the patients were lymphopenic and had had indwelling vascular catheters. Neither patient was neutropenic. The literature on mycobacterial infection in children with cancer is also reviewed.

Keywords

Catheter Internal Medicine Retrospective Analysis Cancer Registry Paediatric Oncology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Navari RM, Sullivan KM, Springmeyer SC, Siegel MS, Meyers JD, Buckner D, Sanders JE, Stewart PS, Clift RA, Fefer A, Storb R, Thomas ED: Mycobacterial infections in marrow transplant patients. Transplantation (1983) 36:509–513PubMedGoogle Scholar
  2. 2.
    Flynn PM, Van Hooser B, Gigliotti F: Atypical mycobacterium infections of Hickman catheter exit sites. Pediatric Infectious Disease Journal (1988) 7:510–513PubMedGoogle Scholar
  3. 3.
    Engler HD, Hass A, Hodes DS, Bottone EJ:Mycobacterium chelonei infection of a Brayiac catheter insertion site. European Journal of Clinical Microbiology & Infectious Diseases (1989) 8:521–523Google Scholar
  4. 4.
    Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Seabury MS: Spectrum of disease due to rapidly growing mycobacteria. Reviews of Infectious Diseases (1983) 5:657–679PubMedGoogle Scholar
  5. 5.
    Hoy JF, Rolston KVI, Hopfer RL, Bodey GP:Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. American Journal of Medicine (1987) 83:213–217PubMedGoogle Scholar
  6. 6.
    Rodgers GL, Mortensen JE, Blecker-Shelly D, Fisher MC, Long SS: Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculousMycobacteria species. Pediatric Infectious Disease Journal (1996) 15:260–264PubMedGoogle Scholar
  7. 7.
    Stone AB, Schelonka RL, Drehner DM, McMahon DP, Ascher DP: DisseminatedMycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. Pediatric Infectious Disease Journal (1992) 11:960–964PubMedGoogle Scholar
  8. 8.
    Schelonka RL, Ascher DP, McMahon DP, Drehner DM, Kuskie MR: Catheter-related sepsis caused byMycobacterium avium complex. Pediatric Infectious Disease Journal (1994) 13:236–238PubMedGoogle Scholar
  9. 9.
    Weinberg M, Berg SL, Feuerstein IM, Pizzo PA, Witebsky FG: Disseminated infection withMycobacterium gordonae: report of a case and critical review of the literature. Clinical Infectious Diseases (1992) 14:1229–1239PubMedGoogle Scholar
  10. 10.
    Holland DJ, Chen SCA, Chew WWK, Gilbert GL:Mycobacterium neoaurum infection of a Hickman catheter in an immunosuppressed patient. Clinical Infectious Diseases (1994) 18:1002–1003PubMedGoogle Scholar
  11. 11.
    Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR: Disseminated infection with rapidly growing mycobacteria. Clinical Infectious Diseases (1993) 16:463–471PubMedGoogle Scholar
  12. 12.
    Horowitz EA, Sanders WE Jr: OtherMycobacterium species. In: Mandell GL, Bennett JE, Dolin R, (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp. 2264–2273Google Scholar
  13. 13.
    Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA:Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. New England Journal of Medicine (1987) 317:197–201PubMedGoogle Scholar
  14. 14.
    McWhinney PHM, Yates M, Prentice HG, Thrussel M, Gillespie SH, Kibbler CC: Infection caused byMycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clinical Infectious Diseases (1992) 14:1208–1212PubMedGoogle Scholar
  15. 15.
    Lovat PE, Robinson JH, Windebank KP, Kernahan J, Watson JG: Serial study of T lymphocytes in childhood leukaemia during remission. Pediatric Hematology and Oncology (1993) 10:129–139PubMedGoogle Scholar
  16. 16.
    Wakiguchi H, Kubota H, Hisakawa H, Fujieda M, Kurashige T: Defective natural killer cell activity and deficient production of interferon-g in children with acute lymphoblastic leukaemia. Acta Paediatrica Japonica (1994) 36:361–365PubMedGoogle Scholar
  17. 17.
    Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-g-receptor gene and susceptibility to mycobacterial infection. New England Journal of Medicine (1996) 335:1941–1949PubMedGoogle Scholar
  18. 18.
    Geertsma MF, Nibbering PH, Pos O, Van Furth R: Interferon-g-activated human granulocytes kill ingestedMycobacterium fortuitum more efficiently than normal granulocytes. European Journal of Immunology (1990) 20:869–873PubMedGoogle Scholar
  19. 19.
    Weinstein RA, Gelmann E, Golomb HM: Disseminated atypical mycobacterial infection in hairy-cell leukaemia. Lancet (1978) ii: 1052–1053Google Scholar
  20. 20.
    Bennett C, Vardiman J, Glob H: Disseminated atypical mycobacterial infection in patients with hairy cell leukaemia. American Journal of Medicine (1986) 80:891–896PubMedGoogle Scholar
  21. 21.
    Wallace RJ Jr, Brown BA, Onyi GO: Skin, soft tissue and bone infections due toMycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. Journal of Infectious Diseases (1992) 122:405–412Google Scholar
  22. 22.
    American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Journal of Respiratory and Critical Care Medicine (1997) 156, Supplement 2:1–25Google Scholar
  23. 23.
    Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG: Treatment of nonpulmonary infections due toMycobacterium fortuitum andMycobacterium chelonei on the basis of in vitro susceptibilities. Journal of Infectious Diseases (1985) 152:500–514PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1998

Authors and Affiliations

  • J. C. Graham
    • 1
  • D. A. Tweddle
    • 2
  • D. R. Jenkins
    • 1
  • C. Pollitt
    • 1
  • S. J. Pedler
    • 1
  1. 1.Department of Clinical Microbiology and Public Health LaboratoryRoyal Victoria Infirmary NHS TrustNewcastle-upon-TyneUK
  2. 2.Department of Child HealthRoyal Victoria Infirmary NHS TrustNewcastle-upon-TyneUK

Personalised recommendations